Company · CIK 0001723069 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Tiziana Life Sciences Ltd · TLSA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 PForm 4 → | Aug 6, 9:30 am EDT | Ivor ElrifiChief Executive Officer | 321,423 | $0.9922 | $318,909 | 4,793,684 | +7.19% | |
| Aug 3, 2026 PForm 4 → | Aug 5, 4:30 pm EDT | Ivor ElrifiChief Executive Officer | 667,000 | $1.00 | $667,000 | 4,472,261 | +17.5% | |
| Jul 21, 2026 PForm 4/A → | Aug 7, 4:16 pm EDT | Gabriele M CerroneDirector, 10% Owner | 42,357 | $0.99 | $41,933 | 44,814,587 | +0.09% | |
| Jul 21, 2026 AForm 4 → | Jul 23, 4:15 pm EDT | Gabriele M CerroneDirector, 10% Owner | 42,357 | $0.99 | $41,933 | 44,814,587 | — | |
| Jun 12, 2026 PForm 4/A → | Aug 7, 4:15 pm EDT | Gabriele M CerroneDirector, 10% Owner | 15,000 | $1.11 | $16,650 | 44,772,230 | +0.03% | |
| Jun 12, 2026 AForm 4 → | Jun 17, 6:31 am EDT | Gabriele M CerroneDirector, 10% Owner | 15,000 | $1.11 | $16,650 | 44,772,230 | — | late amended |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.